Nelson Leung

Active 2002–2025

283
Papers
31,866
Citations
96
h-index
260
i10-index

Citations

Citations per year for Nelson Leung2003: 1 citations2004: 5 citations2005: 4 citations2006: 14 citations2007: 15 citations2008: 31 citations2009: 30 citations2010: 34 citations2011: 75 citations2012: 141 citations2013: 158 citations2014: 140 citations2015: 174 citations2016: 225 citations2017: 175 citations2018: 266 citations2019: 796 citations2020: 1,057 citations2021: 956 citations2022: 797 citations2023: 791 citations2024: 1,499 citations2025: 697 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,401 citing papers, 25.1% of this breakdownChina: 664 citing papers, 7% of this breakdownItaly: 660 citing papers, 6.9% of this breakdownUnited Kingdom: 610 citing papers, 6.4% of this breakdownGermany: 585 citing papers, 6.1% of this breakdownFrance: 498 citing papers, 5.2% of this breakdownSpain: 392 citing papers, 4.1% of this breakdownCanada: 317 citing papers, 3.3% of this breakdownNetherlands: 301 citing papers, 3.2% of this breakdownJapan: 228 citing papers, 2.4% of this breakdownAustralia: 222 citing papers, 2.3% of this breakdownGreece: 218 citing papers, 2.3% of this breakdown
0%25.1%Other 25.7%

Fields

  • Medicine67.6%
  • Biochemistry, Genetics and Molecular Biology23.1%
  • Immunology and Microbiology4.1%
  • Computer Science2.1%
  • Materials Science0.8%
  • Chemistry0.5%
  • Other1.8%

Topics

  • Multiple Myeloma Research and Treatments9%
  • Amyloidosis: Diagnosis, Treatment, Outcomes6.9%
  • Renal Diseases and Glomerulopathies5.3%
  • Protein Degradation and Inhibitors3.6%
  • Lymphoma Diagnosis and Treatment3.5%
  • Chronic Lymphocytic Leukemia Research2.7%
  • Other69%

Coauthors

All papers

Open in search
  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andreas Hochhaus, Patty M. Jansen, Kennosuke Karube, Werner Kempf, Joseph D. Khoury, Hiroshi Kimura, Wolfgang Hiddemann, Alexandra E. Kovach, Shaji Kumar, Alexander J. Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson Leung, Vasiliki Leventaki, Xiao‐Qiu Li, Megan S. Lim, Weiping Liu, Abner Louissaint, Andrea N. Marcogliese, L. Jeffrey Medeiros, Michael Michal, Roberto N. Miranda, Christina Mitteldorf, Santiago Montes‐Moreno, William G. Morice, Valentina Nardi, Kikkeri N. Naresh, Yasodha Natkunam, Siok‐Bian Ng, Ilske Oschlies, German Ott, Marie Parrens, Melissa Pulitzer, S. Vincent Rajkumar, Andy C. Rawstron, Karen L. Rech, Andreas Rosenwald, Jonathan Said, Clémentine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William A. Sewell, Reiner Siebert, Aliyah R. Sohani, Reuben Tooze, Alexandra Traverse‐Glehen, Francisco Vega, B. Vergier, Ashutosh Wechalekar, Brent L. Wood, Luc Xerri, Wenbin Xiao - Leukemia 2022 cited by 3,736

  2. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay Radhakrishnan, Heather N. Reich, Samir V. Parikh, Debbie S. Gipson, Dominic K. Lee, Bruno R. da Costa, Peter Jüni, Daniel Cattran - New England Journal of Medicine 2019 cited by 600

  3. Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 1,124

  4. Cisplatin nephrotoxicity: a review of the literature

    Authors: , - Journal of Nephrology 2017 cited by 629

  5. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    Authors: , , , , , , , , , , , , , , , - Leukemia 2013 cited by 1,396

  6. A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction

    Authors: , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2016 cited by 288

  7. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús F. San Miguel, Kenneth C. Anderson, Edward A. Stadtmauer, Rao Prabhala, Phillip McCarthy, Nikhil C. Munshi - The Lancet Haematology 2022 cited by 191

  8. Systemic amyloidosis from A (AA) to T (ATTR): a review

    Authors: , , , , , , , , , , , - Journal of Internal Medicine 2020 cited by 320

  9. Glomerulonephritis: immunopathogenesis and immunotherapy

    Authors: , , , - Nature reviews. Immunology 2023 cited by 164

  10. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashutosh Wechalekar, Brendan M. Weiss, Samih H. Nasr - Nature Reviews Nephrology 2018 cited by 534

  11. Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Blood Cancer Journal 2018 cited by 289

  12. Monoclonal Gammopathy of Renal Significance

    Authors: , , - New England Journal of Medicine 2021 cited by 191

  13. Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 98

  14. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 cited by 121

  15. Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Hematology 2023 cited by 53

  16. Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events

    Authors: , , , , , , , , , - Kidney International Reports 2021 cited by 108

  17. A simple additive staging system for newly diagnosed multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Cancer Journal 2022 cited by 95

  18. Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1

    Authors: , , , , , , , , , , , , - Journal of the American Society of Nephrology 2022 cited by 108

  19. Mortality trends in multiple myeloma after the introduction of novel therapies in the United States

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2021 cited by 102

  20. Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , An S. De Vriese, Jai Radhakrishnan, Lorraine C. Racusen, Pierre Ronco, Fernando C. Fervenza - Journal of the American Society of Nephrology 2015 cited by 309

  21. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications

    Authors: , , , , , , - Blood 2018 cited by 292

  22. Simulation-Based Approaches for Determining Membrane Permeability of Small Compounds

    Authors: , , , , , , , , , , , - Journal of Chemical Information and Modeling, J. Chem. Inf. Model. 2016 cited by 228

  23. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 419

  24. Biopsy-Proven Acute Interstitial Nephritis, 1993-2011: A Case Series

    Authors: , , , , , , - American Journal of Kidney Diseases 2014 cited by 344